N P Kumar1, B Velayutham2, D Nair2, S Babu3. 1. International Center for Excellence in Research, National Institutes of Health, Chennai, India. 2. National Institutes for Research in Tuberculosis, Chennai, India. 3. International Center for Excellence in Research, National Institutes of Health, Chennai, India; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Abstract
BACKGROUND: Circulating angiogenic factors of the vascular endothelial growth factor family are important biomarkers of disease severity in pulmonary tuberculosis (PTB). However, the role of angiopoietins, which are also involved in angiogenesis, in PTB is not known. OBJECTIVE AND DESIGN: To examine the association of circulating angiopoietins with TB disease or latent tuberculous infection (LTBI), we examined the systemic levels of angiopoietin (Ang) 1, Ang 2 and Tie-2 receptor in individuals with PTB (n = 44), LTBI (n = 44) or no tuberculous infection (NTBI) (n = 44). RESULTS: Circulating levels of Ang-1, Ang-2 and Tie-2 were significantly higher in PTB than in individuals with LTBI or NTBI. Moreover, Ang-1, Ang-2 and Tie-2 levels were significantly higher in PTB with bilateral disease. The levels of these factors also exhibited a significant positive relationship with bacterial burdens in PTB. Receiver operating characteristics curve analysis revealed Ang-2 as a marker distinguishing PTB from LTBI or NTBI. Finally, the circulating levels of Ang-1, Ang-2 and Tie-2 were significantly reduced following anti-tuberculosis chemotherapy. CONCLUSIONS: Our data demonstrate that PTB is associated with elevated levels of circulating angiopoietins, possibly reflecting endothelial dysfunction. In addition, Ang-2 could prove useful as a biomarker to monitor disease severity, bacterial burden and therapeutic responses.
BACKGROUND: Circulating angiogenic factors of the vascular endothelial growth factor family are important biomarkers of disease severity in pulmonary tuberculosis (PTB). However, the role of angiopoietins, which are also involved in angiogenesis, in PTB is not known. OBJECTIVE AND DESIGN: To examine the association of circulating angiopoietins with TB disease or latent tuberculous infection (LTBI), we examined the systemic levels of angiopoietin (Ang) 1, Ang 2 and Tie-2 receptor in individuals with PTB (n = 44), LTBI (n = 44) or no tuberculous infection (NTBI) (n = 44). RESULTS: Circulating levels of Ang-1, Ang-2 and Tie-2 were significantly higher in PTB than in individuals with LTBI or NTBI. Moreover, Ang-1, Ang-2 and Tie-2 levels were significantly higher in PTB with bilateral disease. The levels of these factors also exhibited a significant positive relationship with bacterial burdens in PTB. Receiver operating characteristics curve analysis revealed Ang-2 as a marker distinguishing PTB from LTBI or NTBI. Finally, the circulating levels of Ang-1, Ang-2 and Tie-2 were significantly reduced following anti-tuberculosis chemotherapy. CONCLUSIONS: Our data demonstrate that PTB is associated with elevated levels of circulating angiopoietins, possibly reflecting endothelial dysfunction. In addition, Ang-2 could prove useful as a biomarker to monitor disease severity, bacterial burden and therapeutic responses.
Authors: Nicholas W Gale; Gavin Thurston; Sean F Hackett; Roumiana Renard; Quan Wang; Joyce McClain; Cliff Martin; Charles Witte; Marlys H Witte; David Jackson; Chitra Suri; Peter A Campochiaro; Stanley J Wiegand; George D Yancopoulos Journal: Dev Cell Date: 2002-09 Impact factor: 12.270
Authors: Y Abe; M Nakamura; Y Oshika; H Hatanaka; T Tokunaga; Y Ohkubo; T Hashizume; K Suzuki; T Fujino Journal: Respiration Date: 2001 Impact factor: 3.580
Authors: W Matsuyama; T Hashiguchi; K Matsumuro; F Iwami; Y Hirotsu; M Kawabata; K Arimura; M Osame Journal: Am J Respir Crit Care Med Date: 2000-09 Impact factor: 21.405
Authors: Tsin W Yeo; Daniel A Lampah; Retno Gitawati; Emiliana Tjitra; Enny Kenangalem; Kim Piera; Ric N Price; Stephen B Duffull; David S Celermajer; Nicholas M Anstey Journal: Proc Natl Acad Sci U S A Date: 2008-10-28 Impact factor: 11.205
Authors: Charalampos Moschos; Ioannis Psallidas; Androniki Kollintza; Sophia Karabela; Andreas Papapetropoulos; Spyros Papiris; Richard W Light; Charis Roussos; Georgios T Stathopoulos; Ioannis Kalomenidis Journal: Neoplasia Date: 2009-03 Impact factor: 5.715
Authors: Matijs van Meurs; Philipp Kümpers; Jack J M Ligtenberg; John H J M Meertens; Grietje Molema; Jan G Zijlstra Journal: Crit Care Date: 2009-03-09 Impact factor: 9.097
Authors: Pavan K Bhatraju; Katie B Hisert; Moira L Aitken; Christopher H Goss; W Conrad Liles; William A Altemeier Journal: Ann Am Thorac Soc Date: 2019-06
Authors: G R Kathamuthu; K Moideen; D Baskaran; G Sekar; S Rathinam; V J Bharathi; G R Ganeshan; S Babu Journal: Int J Tuberc Lung Dis Date: 2018-05-01 Impact factor: 2.373